Related Experiment Video

Updated: Aug 10, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.6K

The 2022 H3D Symposium: Celebrating over a Decade of African-Led Infectious Disease Drug Discovery to Enhance Global

John G Woodland1,2, Gregory S Basarab1, Koketso Mogwera1

  • 1Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Rondebosch 7700, South Africa.

ACS Infectious Diseases
|February 10, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
07:59

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis

Published on: May 18, 2016

7.8K

Related Experiment Videos

Last Updated: Aug 10, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.6K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
07:59

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis

Published on: May 18, 2016

7.8K

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

155
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
155

Articles linked to this work by shared authors, journal, and citation graph.

New thinking for the next generation of antimalarials.

EMBO molecular medicine·2026

Bridging the AI Divide in Drug Discovery: Practical Lessons from Capacity Strengthening in Africa.

Journal of medicinal chemistry·2026

The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity against the Human Malaria Parasite Plasmodium falciparum via Polypharmacological Inhibition of PfArk1 and Hemozoin Formation.

ACS chemical biology·2026

Effect of Stereochemistry on the Antiplasmodial Activity and Metabolomic Profile of Novel Tadalafil Analogues.

ACS medicinal chemistry letters·2026

Small-molecule IGF1R inhibitors extend healthspan in a mouse model.

bioRxiv : the preprint server for biology·2026

Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative Study.

ACS omega·2026

NIE Antigen Mapping for Serological Diagnostic of Strongyloidiasis.

ACS infectious diseases·2026

A Pathogen-Hopping Approach for the Identification of Compounds with Multistage Antischistosomal Activity.

ACS infectious diseases·2026

Molecular Architecture and Catalytic Mechanisms of Class D Carbapenemases: Insights into Antibiotic Resistance and Carbapenem Design.

ACS infectious diseases·2026

Fatty Acid Biosynthesis Inhibitors─Fabimycin and Triclosan─Trigger Distinct Resistance Mutations in FabI and Potently Kill Gram-Negative Pathogens.

ACS infectious diseases·2026

Mechanistic Roles of Conserved Active-Site Residues in OXA-48 Carbapenem Hydrolysis.

ACS infectious diseases·2026

In Vitro and In Vivo Activity against Staphylococcus aureus and Pharmacokinetic Evaluation of a Novel Pleuromutilin Candidate.

ACS infectious diseases·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us